Innoviva (INVA) Equity Income (2022 - 2026)
Innoviva (INVA) reported Equity Income of -$131.83 million for Q2 2026, compared with $13.08 million a year earlier.
Powered by 
Analysis
Innoviva (INVA) Equity Income (2022 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Innoviva's Equity Income came in at $167.72 million; for FY2025, it was $141.43 million.
- Equity Income has a five-year compound annual growth rate of 23.4% (FY2020 to FY2025).
- By year, Equity Income came in at -$64.25 million in FY2024, $77.39 million in FY2023, -$161.75 million in FY2022 and $84.39 million in FY2021 (+70.5%).
- The Q2 2026 figure ranks as the lowest quarterly Equity Income in data going back to Q1 2022.
- Per Business Quant data, the three quarters before Q2 2026 came in at $157.65 million (Q1 2026), $111.15 million (Q4 2025) and $30.75 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -10.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Innoviva | 1.54 Bn | -750.13 Mn | 90.62 Mn | -131.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -131.83 Mn |
| Mar 31, 2026 | 157.65 Mn |
| Dec 31, 2025 | 111.15 Mn |
| Sep 30, 2025 | 30.75 Mn |
| Jun 30, 2025 | 13.08 Mn |
| Mar 31, 2025 | -13.55 Mn |
| Dec 31, 2024 | -21.26 Mn |
| Sep 30, 2024 | -18.23 Mn |
| Jun 30, 2024 | -60.11 Mn |
| Mar 31, 2024 | 35.34 Mn |
| Sep 30, 2023 | 71.98 Mn |
| Jun 30, 2023 | -19.91 Mn |
| Mar 31, 2023 | 15.82 Mn |
| Sep 30, 2022 | 10.30 Mn |
| Jun 30, 2022 | -42.82 Mn |
| Mar 31, 2022 | -11.95 Mn |
API Access
Innoviva Equity Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=equity-income&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "equity-income", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=equity-income&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();